Published in J Lipid Res on January 01, 1996
In vivo resistance of lipolysis to epinephrine. A new feature of childhood onset obesity. J Clin Invest (1997) 1.01
The Trp64Arg mutation of the beta3 adrenergic receptor gene has no effect on obesity phenotypes in the Québec Family Study and Swedish Obese Subjects cohorts. J Clin Invest (1996) 0.96
The preferential beta3-adrenoceptor agonist BRL 37344 increases force via beta1-/beta2-adrenoceptors and induces endothelial nitric oxide synthase via beta3-adrenoceptors in human atrial myocardium. Br J Pharmacol (2003) 0.94
A selective human beta3 adrenergic receptor agonist increases metabolic rate in rhesus monkeys. J Clin Invest (1998) 0.88
Metabolic effects of antihypertensive agents: role of sympathoadrenal and renin-angiotensin systems. Naunyn Schmiedebergs Arch Pharmacol (2006) 0.87
Human atrial β(1L)-adrenoceptor but not β₃-adrenoceptor activation increases force and Ca(2+) current at physiological temperature. Br J Pharmacol (2011) 0.86
Selective release of human adipocyte fatty acids according to molecular structure. Biochem J (1997) 0.84
Relationships between Rodent White Adipose Fat Pads and Human White Adipose Fat Depots. Front Nutr (2016) 0.75
Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci U S A (1986) 15.20
p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature (1999) 14.38
p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell (1998) 11.54
Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell (1997) 7.27
Homologies in both primary and secondary structure between nuclear envelope and intermediate filament proteins. Nature (1986) 5.90
p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature (2000) 5.83
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett (1994) 5.30
MPF from starfish oocytes at first meiotic metaphase is a heterodimer containing one molecule of cdc2 and one molecule of cyclin B. EMBO J (1989) 4.05
ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett (1994) 3.78
Identification of TIAR as a protein binding to the translational regulatory AU-rich element of tumor necrosis factor alpha mRNA. J Biol Chem (1999) 3.43
Human epidermal growth factor precursor: cDNA sequence, expression in vitro and gene organization. Nucleic Acids Res (1986) 3.11
Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif. J Biol Chem (2000) 3.01
Leptin, the product of Ob gene, promotes angiogenesis. Circ Res (1998) 2.63
Primary structure and gene organization of human hepatitis A virus. Proc Natl Acad Sci U S A (1985) 2.43
Remodeling phenotype of human subcutaneous adipose tissue macrophages. Circulation (2008) 2.38
Functional beta3-adrenoceptor in the human heart. J Clin Invest (1996) 2.32
Leptin induces oxidative stress in human endothelial cells. FASEB J (1999) 2.32
Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine. J Exp Med (1994) 2.29
Natriuretic peptides: a new lipolytic pathway in human adipocytes. FASEB J (2000) 2.24
Studies on the expression of the microtubule-associated protein, tau, during mouse brain development, with newly isolated complementary DNA probes. J Cell Biol (1984) 2.05
Differential expression of multiple U1 small nuclear RNAs in oocytes and embryos of Xenopus laevis. Cell (1984) 1.98
Fat cell adrenergic receptors and the control of white and brown fat cell function. J Lipid Res (1993) 1.90
The 100-kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor. J Biol Chem (1998) 1.84
Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation. Diabetes (2001) 1.71
Expression cloning of an interferon-inducible 17-kDa membrane protein implicated in the control of cell growth. J Biol Chem (1995) 1.64
Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor. FEBS Lett (1993) 1.62
Cloning of human purine-nucleoside phosphorylase cDNA sequences by complementation in Escherichia coli. Proc Natl Acad Sci U S A (1983) 1.61
IL-13 alters mucociliary differentiation and ciliary beating of human respiratory epithelial cells. J Clin Invest (2001) 1.60
Cloning of the human IL-13R alpha1 chain and reconstitution with the IL4R alpha of a functional IL-4/IL-13 receptor complex. FEBS Lett (1997) 1.57
An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. J Biol Chem (1995) 1.54
p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53. J Biol Chem (1999) 1.53
Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-gamma. Eur J Immunol (1994) 1.52
Viral oncoproteins discriminate between p53 and the p53 homolog p73. Mol Cell Biol (1998) 1.51
Exon-intron organization and chromosomal localization of the mouse monoglyceride lipase gene. Gene (2001) 1.49
Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors. FEBS Lett (1993) 1.48
The synthesis and stability of cytoplasmic messenger RNA during myoblast differentiation in culture. Proc Natl Acad Sci U S A (1974) 1.44
Heterogeneous distribution of beta and alpha-2 adrenoceptor binding sites in human fat cells from various fat deposits: functional consequences. Eur J Clin Invest (1987) 1.43
A simple and highly sensitive radioenzymatic assay for lysophosphatidic acid quantification. J Lipid Res (2000) 1.42
Interleukin 13 is a B cell stimulating factor. J Exp Med (1994) 1.41
cDNA cloning of a human mRNA preferentially expressed in hematopoietic cells and with homology to a GDP-dissociation inhibitor for the rho GTP-binding proteins. Proc Natl Acad Sci U S A (1993) 1.41
Coexistence of three beta-adrenoceptor subtypes in white fat cells of various mammalian species. Eur J Pharmacol (1991) 1.40
[Frequency of malaria in adult expatriates consulting for a fever in 4 medical-social centers in Africa]. Med Trop (Mars) (1998) 1.39
Alpha-adrenergic antilipolytic effect of adrenaline in human fat cells of the thigh: comparison with adrenaline responsiveness of different fat deposits. Eur J Clin Invest (1979) 1.35
Increased uncoupling protein-2 and -3 mRNA expression during fasting in obese and lean humans. J Clin Invest (1997) 1.33
Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition. Diabetologia (2005) 1.33
Molecular cloning of a levocabastine-sensitive neurotensin binding site. FEBS Lett (1996) 1.32
The immunosuppressant SR 31747 blocks cell proliferation by inhibiting a steroid isomerase in Saccharomyces cerevisiae. Mol Cell Biol (1996) 1.30
Cloning and mRNA tissue distribution of human PPARgamma coactivator-1. Int J Obes Relat Metab Disord (1999) 1.28
Decreased expression and function of adipocyte hormone-sensitive lipase in subcutaneous fat cells of obese subjects. J Lipid Res (1999) 1.25
Characterization of the polypeptide composition of human factor VIII:C and the nucleotide sequence and expression of the human kidney cDNA. DNA (1985) 1.25
Bifunctional thymidylate synthase-dihydrofolate reductase from Leishmania tropica: sequence homology with the corresponding monofunctional proteins. Proc Natl Acad Sci U S A (1986) 1.24
Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor. Biochim Biophys Acta (1996) 1.23
Effects of hypoxia on the expression of proangiogenic factors in differentiated 3T3-F442A adipocytes. Int J Obes Relat Metab Disord (2003) 1.22
p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent. Oncogene (1999) 1.22
Alpha 2-antagonist compounds and lipid mobilization: evidence for a lipid mobilizing effect of oral yohimbine in healthy male volunteers. Eur J Clin Invest (1988) 1.20
The related cytokines interleukin-13 and interleukin-4 are distinguished by differential production and differential effects on T lymphocytes. Eur Cytokine Netw (1997) 1.20
Local sympathetic denervation of white adipose tissue in rats induces preadipocyte proliferation without noticeable changes in metabolism. Endocrinology (1993) 1.19
Adrenergic supersensitivity in parkinsonians with orthostatic hypotension. Eur J Clin Invest (1990) 1.18
Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats. J Immunol (1994) 1.18
Real-time RT-PCR for the detection of beta-adrenoceptor messenger RNAs in small human endomyocardial biopsies. J Mol Cell Cardiol (2001) 1.18
Cloning and expression in Escherichia coli of the gene encoding Aspergillus flavus urate oxidase. J Biol Chem (1992) 1.17
Adipose tissue gene expression in obese subjects during low-fat and high-fat hypocaloric diets. Diabetologia (2004) 1.16
Effects of yohimbine on submaxillary salivation in dogs. Br J Pharmacol (1989) 1.15
In situ assessment of the role of the beta 1-, beta 2- and beta 3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue. Br J Pharmacol (1996) 1.14
Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells. Naunyn Schmiedebergs Arch Pharmacol (1999) 1.14
Atrial natriuretic peptide inhibits the production of adipokines and cytokines linked to inflammation and insulin resistance in human subcutaneous adipose tissue. Diabetologia (2007) 1.13
Dynamic strength training improves insulin sensitivity without altering plasma levels and gene expression of adipokines in subcutaneous adipose tissue in obese men. J Clin Endocrinol Metab (2006) 1.13
Mechanism of the lipid-mobilizing effect of alpha-2 adrenergic antagonists in the dog. J Pharmacol Exp Ther (1988) 1.11
Angiogenesis in adipose tissue. Ann Endocrinol (Paris) (2002) 1.11
Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro. J Exp Med (1993) 1.11
Regulation of inflammation-related genes in human adipose tissue. J Intern Med (2007) 1.10
Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A. J Biol Chem (1996) 1.09
Pharmacological prospects for alpha 2-adrenoceptor antagonist therapy. Trends Pharmacol Sci (1992) 1.09
Yohimbine increases human salivary secretion. Br J Clin Pharmacol (1989) 1.07
Adipocyte hormone-sensitive lipase: a major regulator of lipid metabolism. Proc Nutr Soc (1996) 1.07
Alpha2-adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes. A paracrine signal for preadipocyte growth. J Clin Invest (1998) 1.07